# Charles H. Adler

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/charles-h-adler/

## Facts

| Field | Value |
| --- | --- |
| Citations | 46,464 |
| Field | Parkinson's Disease Mechanisms and Treatments |
| h-index | 93 |
| i10-index | 319 |
| Last Known Institution | WinnMed |
| OpenAlex ID | https://openalex.org/A5024500161 |
| ORCID iD | https://orcid.org/0000-0002-1045-2743 |
| Works | 513 |

## Researcher papers

- [MDS clinical diagnostic criteria for Parkinson's disease](https://scholariq.org/papers/mds-clinical-diagnostic-criteria-for-parkinson-s-disease/)
- [Diagnostic criteria for mild cognitive impairment in Parkinson's disease: <i>Movement</i> Disorder Society Task Force guidelines](https://scholariq.org/papers/diagnostic-criteria-for-mild-cognitive-impairment-in-parkinson-s-disease-i/)
- [MDS research criteria for prodromal Parkinson's disease](https://scholariq.org/papers/mds-research-criteria-for-prodromal-parkinson-s-disease/)
- [<i>PGC-1</i> α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease](https://scholariq.org/papers/i-pgc-1-i-a-potential-therapeutic-target-for-early-intervention-in-parkinson-s/)
- [Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder](https://scholariq.org/papers/clinicopathologic-correlations-in-172-cases-of-rapid-eye-movement-sleep-behavior/)
- [Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder](https://scholariq.org/papers/biomarkers-of-conversion-to-synucleinopathy-in-isolated-rapid-eye-movement-sleep/)
- [In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease](https://scholariq.org/papers/in-vivo-distribution-of-synuclein-in-multiple-tissues-and-biofluids-in-parkinson/)

## Researcher topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Botulinum Toxin and Related Neurological Disorders](https://scholariq.org/topics/botulinum-toxin-and-related-neurological-disorders/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)

## Researcher university

- [WinnMed](https://scholariq.org/institutions/winnmed/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
